CollPlant developing collagen-based bioinks for 3D bioprinting tissues and organs
Regenerative medicine company CollPlant (Israel) has received funding from the Israeli government to support their development of human collagen-based bioinks to support tissue engineering for burn and wound healing.
Please sign in or register for FREE
Sign in to 3DMedNet
Register to 3DMedNet
3DMedNet is a free content and networking hub aiming to encourage knowledge-sharing, interaction and discussion within the diverse 3D printing in medicine and healthcare community.